ScoreWhy is Applied DNA Sciences, Inc. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.95
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -96.83%, its profits have fallen by -78.7%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -3.05% over the previous quarter and currently hold 2.62% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
4
Below par performance in long term as well as near term
- Along with generating -96.83% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Applied DNA Sciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Applied DNA Sciences, Inc.
-96.83%
-0.67
148.35%
S&P 500
15.76%
1.22
13.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-6.77%
EBIT Growth (5y)
-32.19%
EBIT to Interest (avg)
-12.95
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
1.25
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.48%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.20
EV to EBIT
-0.03
EV to EBITDA
-0.03
EV to Capital Employed
0.04
EV to Sales
0.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-152.67%
ROE (Latest)
-122.75%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -11.96 MM
NET SALES(HY)
At USD 1.63 MM has Grown at 52.68%
RAW MATERIAL COST(Y)
Fallen by -371.42% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 19.64 times
OPERATING PROFIT(Q)
Highest at USD -1.87 MM
PRE-TAX PROFIT(Q)
Highest at USD -1.86 MM
NET PROFIT(Q)
Highest at USD -1.87 MM
EPS(Q)
Highest at USD -0.57
-9What is not working for the Company
NET PROFIT(9M)
At USD -17.28 MM has Grown at -76.2%
ROCE(HY)
Lowest at -421.43%
DEBT-EQUITY RATIO
(HY)
Highest at 0.88 %
CASH AND EQV(HY)
Lowest at USD 4.71 MM
Here's what is working for Applied DNA Sciences, Inc.
Operating Cash Flow
Highest at USD -11.96 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
At USD 1.63 MM has Grown at 52.68%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD -1.87 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD -1.86 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -1.86 MM has Grown at 66.8%
over average net sales of the previous four periods of USD -5.61 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -1.87 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD -1.87 MM has Grown at 65.41%
over average net sales of the previous four periods of USD -5.4 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.57
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 19.64 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -371.42% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Applied DNA Sciences, Inc.
Debt-Equity Ratio
Highest at 0.88 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Cash and Eqv
Lowest at USD 4.71 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Footer loading
